Australia markets close in 59 minutes

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2500-0.0800 (-3.43%)
At close: 04:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 29.72M
Enterprise value 26.02M
Trailing P/E N/A
Forward P/E 526.32
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.17
Price/book (mrq)2.40
Enterprise value/revenue 0.31
Enterprise value/EBITDA -0.84

Trading information

Stock price history

Beta (5Y monthly) 1.87
52-week change 3-90.00%
S&P500 52-week change 3-12.31%
52-week high 332.4000
52-week low 31.5300
50-day moving average 32.9504
200-day moving average 35.1508

Share statistics

Avg vol (3-month) 344.3k
Avg vol (10-day) 353.47k
Shares outstanding 512.76M
Implied shares outstanding 6N/A
Float 86.08M
% held by insiders 121.58%
% held by institutions 115.00%
Shares short (14 Nov 2022) 4189k
Short ratio (14 Nov 2022) 42.29
Short % of float (14 Nov 2022) 43.10%
Short % of shares outstanding (14 Nov 2022) 42.80%
Shares short (prior month 13 Oct 2022) 4180.54k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 316 May 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -73.11%
Operating margin (ttm)-65.53%

Management effectiveness

Return on assets (ttm)-27.85%
Return on equity (ttm)-350.69%

Income statement

Revenue (ttm)83.24M
Revenue per share (ttm)14.05
Quarterly revenue growth (yoy)-1.80%
Gross profit (ttm)62.76M
EBITDA -52.19M
Net income avi to common (ttm)-62.42M
Diluted EPS (ttm)-14.8540
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.85M
Total cash per share (mrq)2.05
Total debt (mrq)11.16M
Total debt/equity (mrq)90.19
Current ratio (mrq)1.92
Book value per share (mrq)1.85

Cash flow statement

Operating cash flow (ttm)-55.97M
Levered free cash flow (ttm)-41.47M